Filed: 8/13/2025ACC: 0001766721-25-000004
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $359.67M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$359.67M
Total AUM (reported)
20.03M
Total Shares
Allocation by class
COM$291.62M81.1%
SPONSORED ADS$61.56M17.1%
COM CL A$5.17M1.4%
COM NEW$1.33M0.4%
Portfolio Concentration
Top 3$332.55M92.5%
4–10$25.80M7.2%
11–25$1.33M0.4%
Top 3 weight
92.5%
Top 10 weight
99.6%
Voting Authority Distribution
Total shares with voting rights: 20.03M
Sole
Full voting authority
20.03M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$262.02M
72.85%
Sole
6.07M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares615.35K
TypeSH
Market value$58.20M
16.18%
Sole
615.35K
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.32M
TypeSH
Market value$12.33M
3.43%
Sole
1.32M
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.47M
TypeSH
Market value$6.64M
1.85%
Sole
1.47M
Shared
0.00
None
0.00
Bicara Therapeutics Inc. (BCAX)
SOLEShares568.92K
TypeSH
Market value$5.29M
1.47%
Sole
568.92K
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$4.95M
1.38%
Sole
2.54M
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares2.05M
TypeSH
Market value$3.69M
1.03%
Sole
2.05M
Shared
0.00
None
0.00
Compass Pathways Plc (CMPS)
SOLEShares1.20M
TypeSH
Market value$3.36M
0.93%
Sole
1.20M
Shared
0.00
None
0.00
Elevation Oncology Inc (ELEV)
SOLEShares2.83M
TypeSH
Market value$1.04M
0.29%
Sole
2.83M
Shared
0.00
None
0.00
CalciMedica, Inc. (CALC)
SOLEShares521.11K
TypeSH
Market value$833.8K
0.23%
Sole
521.11K
Shared
0.00
None
0.00
Aclaris Therapeutics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$616.9K
0.17%
Sole
434.45K
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares325.37K
TypeSH
Market value$497.8K
0.14%
Sole
325.37K
Shared
0.00
None
0.00
OnKure Therapeutics, Inc. (OKUR)
SOLEShares88.61K
TypeSH
Market value$211.8K
0.06%
Sole
88.61K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $262.02M 72.85% | 6.07M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 615.35K | SH | $58.20M 16.18% | 615.35K | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.32M | SH | $12.33M 3.43% | 1.32M | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.47M | SH | $6.64M 1.85% | 1.47M | 0.00 | 0.00 |
Bicara Therapeutics Inc. (BCAX)SOLE | COM | 568.92K | SH | $5.29M 1.47% | 568.92K | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $4.95M 1.38% | 2.54M | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 2.05M | SH | $3.69M 1.03% | 2.05M | 0.00 | 0.00 |
Compass Pathways Plc (CMPS)SOLE | SPONSORED ADS | 1.20M | SH | $3.36M 0.93% | 1.20M | 0.00 | 0.00 |
Elevation Oncology Inc (ELEV)SOLE | COM | 2.83M | SH | $1.04M 0.29% | 2.83M | 0.00 | 0.00 |
CalciMedica, Inc. (CALC)SOLE | COM NEW | 521.11K | SH | $833.8K 0.23% | 521.11K | 0.00 | 0.00 |
Aclaris Therapeutics Inc (ACRS)SOLE | COM | 434.45K | SH | $616.9K 0.17% | 434.45K | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM NEW | 325.37K | SH | $497.8K 0.14% | 325.37K | 0.00 | 0.00 |
OnKure Therapeutics, Inc. (OKUR)SOLE | COM CL A | 88.61K | SH | $211.8K 0.06% | 88.61K | 0.00 | 0.00 |